Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Land & Improvements (2016 - 2024)

Utah Medical Products (UTMD) has 12 years of Land & Improvements data on record, last reported at $1.6 million in Q4 2024.

  • For Q4 2024, Land & Improvements fell 2.08% year-over-year to $1.6 million; the TTM value through Dec 2024 reached $1.6 million, down 2.08%, while the annual FY2024 figure was $1.6 million, 2.08% down from the prior year.
  • Land & Improvements reached $1.6 million in Q4 2024 per UTMD's latest filing, down from $1.6 million in the prior quarter.
  • Across five years, Land & Improvements topped out at $1.7 million in Q4 2020 and bottomed at $1.6 million in Q4 2022.
  • Average Land & Improvements over 5 years is $1.6 million, with a median of $1.6 million recorded in 2023.
  • Peak YoY movement for Land & Improvements: rose 3.23% in 2020, then dropped 5.74% in 2022.
  • A 5-year view of Land & Improvements shows it stood at $1.7 million in 2020, then decreased by 2.03% to $1.7 million in 2021, then decreased by 5.74% to $1.6 million in 2022, then grew by 2.82% to $1.6 million in 2023, then dropped by 2.08% to $1.6 million in 2024.
  • Per Business Quant database, its latest 3 readings for Land & Improvements were $1.6 million in Q4 2024, $1.6 million in Q4 2023, and $1.6 million in Q4 2022.